#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Warm autoimmune haemolytic anaemia Retinopathy of prematurity Neuroblastoma recurrent B-cell lymphoma recurrent Neurofibroma Neuroendocrine cell hyperplasia of infancy Neurodegenerative disorder Alexander disease Brain injury Duchenne muscular dystrophy Bronchopulmonary aspergillosis B-cell small lymphocytic lymphoma PIK3CA-activated mutation Marginal zone lymphoma refractory Juvenile idiopathic arthritis More trials…

    Learn about Rare Diseases

    MELAS syndrome – Life with Disease Haemophilia – Treatment Crigler-Najjar syndrome – Life with Disease Synovial sarcoma – Treatment Haemophilia A with anti factor VIII – Life with Disease Prader-Willi syndrome – Basic Information Hypereosinophilic syndrome – Trials in Disease Carcinoid syndrome – Treatment Alagille syndrome – Diagnostics Congenital nephrogenic diabetes insipidus More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Immunostimulants Desvenlafaxine Benzoate Hydroxypropylbetadex Sodium Acetate Trihydrate Kpl-404 Laronidase Rusfertide Potassium Iodide Cabergoline Vh4524184 Bepirovirsen Sodium Alginate Forimtamig Ly3541860 Lbl-007 C1 Esterase Inhibitor (Human) Furosemide Ph. Eur. Naltrexone Hydrochloride Edg-5506 Davutamig More therapies…

    Learn about Your Condition

    Peripheral artery restenosis Lymphangioleiomyomatosis Laparoscopic surgery Pyoderma Malignant neoplasm of choroid Round cell liposarcoma Arteriosclerosis Kaposi's sarcoma Bile duct adenocarcinoma Varicella Diabetic foot infection Liposarcoma Cardiac arrest Infertility Endometrial cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Female Urogenital Diseases and Pregnancy Complications

  • Progesterone as an Ovulation Trigger in Women with Infertility

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Progesterone
    Portugal

  • Comparison of ceftriaxone and azithromycin versus amoxicillin and azithromycin for pregnant women with preterm premature rupture of membranes between 22 and 33 weeks.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Abortion threatened
    Investigated Drugs:
    • Azithromycin
    • Amoxicillin
    • Ceftriaxone
    France

  • A study to evaluate the safety and effectiveness of nivolumab and imiquimod in adults with vulvar squamous cell carcinoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Vulval cancer
    Investigated Drugs:
    • Imiquimod
    • Nivolumab
    France

  • A study to evaluate the effect of valproic acid in women of reproductive age with adenomyosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Adenomyosis
    Investigated Drugs:
    • Ibuprofen
    • Sodium Valproate
    • Sodium Chloride
    Bulgaria

  • Using a drug combination to treat vaginal flora abnormalities in pregnant women at high risk of preterm birth.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Bacterial vaginosis
    Investigated Drugs:
    • Azithromycin Dihydrate
    • Clotrimazole
    • Metronidazole
    France

  • Study of methenamine hippurate compared to a drug combination for preventing recurrent urinary tract infections in women

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Urinary tract infection
    Investigated Drugs:
    • Cefalexin
    • Fosfomycin Trometamol
    • Sulfamethoxazole
    Spain
Previous Page
1 … 17 18 19 20 21 … 32
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!